Abstract
The INSPIRE study working group launched its initial workshop in February 2015 to facilitate collaboration among key stakeholders interested in automated insulin delivery (AID) systems and the psychosocial outcomes of individuals who may use these new technologies. Specifically, the INSPIRE team's goal is to facilitate measure development assessing the psychosocial factors associated with AID systems. A second working group was held to foster exchange among key stakeholders in AID system development. Patient, health care provider, engineering, industry, academic, regulatory and payer perspectives were presented. The INSPIRE working group will continue to serve as a platform to encourage open dialogue among all stakeholders with the aim of facilitating technology that offers minimal user burden and maximum benefit from both a psychological and physiologic perspective.
Original language | English (US) |
---|---|
Pages (from-to) | 799-801 |
Number of pages | 3 |
Journal | Journal of Diabetes Science and Technology |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2016 |
Keywords
- artificial pancreas
- automated insulin delivery
- diabetes technology
- human factors
- psychosocial
ASJC Scopus subject areas
- Bioengineering
- Internal Medicine
- Biomedical Engineering
- Endocrinology, Diabetes and Metabolism